SubHero Banner
Text

November 2024

Core topics in this month’s edition include:

  • Biihera® (zanidatamab-hrii) – New orphan drug approval
  • Radicava® (edaravone) intravenous - Drug discontinuation 
  • Bimzelx® (bimekizumab-bkzx) - New indication

Download PDF

Text